Cargando…
Esophageal Injury Due to Long-term Use of Dabigatran
Autores principales: | Maeda, Akihiro, Fujikawa, Hirohisa, Wakabayashi, Tadamasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136544/ https://www.ncbi.nlm.nih.gov/pubmed/35332769 http://dx.doi.org/10.4274/balkanmedj.galenos.2022.2021-12-145 |
Ejemplares similares
-
Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015) -
Prominent J Waves and Ventricular Fibrillation Caused by Myocarditis and Pericarditis After BNT162b2 mRNA COVID-19 Vaccination
por: Uesako, Hayata, et al.
Publicado: (2022) -
Idarucizumab: A novel antidote for reversal of dabigatran
por: Rehman, Abdul, et al.
Publicado: (2016) -
Dabigatran-induced esophageal injury: a case report
por: Zhang, Jing-Rui, et al.
Publicado: (2020) -
Unrestricted prescription of dabigatran: Is it safe in a resource-limited setting
por: Ghosh, Supradip
Publicado: (2013)